PhD Kazumasa Takenaka MD

  • Citations Per Year
Learn More
Oncogenic gene mutations observed in lung adenocarcinomas, such as epidermal growth factor receptor (EGFR) and KRAS, have some predictive value for chemotherapeutic drugs or EGFR–tyrosine kinase inhibitors. However, the influence of these gene alterations on patients’ prognosis remains controversial. We retrospectively analyzed the tumors of 180 patients(More)
  • 1